| What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? H Knegtering, A Van Der Moolen, S Castelein, H Kluiter, ... Psychoneuroendocrinology 28, 109-123, 2003 | 299 | 2003 |
| Auditory hallucinations in schizophrenia are associated with reduced functional connectivity of the temporo-parietal area A Vercammen, H Knegtering, JA den Boer, EJ Liemburg, A Aleman Biological psychiatry 67 (10), 912-918, 2010 | 293 | 2010 |
| Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. L Wunderink, FJ Nienhuis, S Sytema, CJ Slooff, R Knegtering, D Wiersma Journal of Clinical Psychiatry 68 (5), 654, 2007 | 290 | 2007 |
| The effectiveness of peer support groups in psychosis: a randomized controlled trial S Castelein, R Bruggeman, JT Van Busschbach, M Van Der Gaag, ... Acta Psychiatrica Scandinavica 118 (1), 64-72, 2008 | 237 | 2008 |
| Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis JJ Dlabač-de Lange, R Knegtering, A Aleman Journal of Clinical Psychiatry 71 (4), 411, 2010 | 232 | 2010 |
| Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts E Liemburg, S Castelein, R Stewart, M van der Gaag, A Aleman, ... Journal of psychiatric research 47 (6), 718-725, 2013 | 217 | 2013 |
| Treatment of negative symptoms: where do we stand, and where do we go? A Aleman, TM Lincoln, R Bruggeman, I Melle, J Arends, C Arango, ... Schizophrenia research 186, 55-62, 2017 | 213 | 2017 |
| Predominant role of the 9-hydroxy metabolite of risperidone in elevating blood prolactin levels R Knegtering, P Baselmans, S Castelein, F Bosker, R Bruggeman, ... American Journal of Psychiatry 162 (5), 1010-1012, 2005 | 202 | 2005 |
| A systematic review of instruments to measure depressive symptoms in patients with schizophrenia IM Lako, R Bruggeman, H Knegtering, D Wiersma, RA Schoevers, ... Journal of affective disorders 140 (1), 38-47, 2012 | 198 | 2012 |
| The facts about sexual (Dys) function in schizophrenia: an overview of clinically relevant findings MK de Boer, S Castelein, D Wiersma, RA Schoevers, H Knegtering Schizophrenia bulletin 41 (3), 674-686, 2015 | 194 | 2015 |
| A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning R Knegtering, S Castelein, H Bous, J Van Der Linde, R Bruggeman, ... Journal of Clinical Psychopharmacology 24 (1), 56-61, 2004 | 189 | 2004 |
| Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory–verbal hallucinations in schizophrenia: a randomized controlled trial A Vercammen, H Knegtering, R Bruggeman, HM Westenbroek, JA Jenner, ... Schizophrenia research 114 (1-3), 172-179, 2009 | 172 | 2009 |
| Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: meta-analysis of controlled trials A Aleman, S Enriquez-Geppert, H Knegtering, JJ Dlabac-de Lange Neuroscience & Biobehavioral Reviews 89, 111-118, 2018 | 156 | 2018 |
| Functional connectivity of the temporo-parietal region in schizophrenia: effects of rTMS treatment of auditory hallucinations A Vercammen, H Knegtering, EJ Liemburg, JA den Boer, A Aleman Journal of psychiatric research 44 (11), 725-731, 2010 | 133 | 2010 |
| The specificity of neurological signs in schizophrenia: a review MPM Boks, S Russo, R Knegtering, RJ van den Bosch Schizophrenia research 43 (2-3), 109-116, 2000 | 133 | 2000 |
| Effects of antidepressants on cognitive functioning of elderly patients: a review H Knegtering, M Eijck, A Huijsman Drugs & aging 5, 192-199, 1994 | 132 | 1994 |
| Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin? H Knegtering, R van den Bosch, S Castelein, R Bruggeman, S Sytema, ... Psychoneuroendocrinology 33 (6), 711-717, 2008 | 121 | 2008 |
| Neurological soft signs discriminating mood disorders from first episode schizophrenia MPM Boks, PF Liddle, JGM Burgerhof, R Knegtering, RJ Van den Bosch Acta Psychiatrica Scandinavica 110 (1), 29-35, 2004 | 119 | 2004 |
| Estimating dopamine D2 receptor occupancy for doses of 8 antipsychotics: a meta-analysis IM Lako, ER van den Heuvel, H Knegtering, R Bruggeman, K Taxis Journal of clinical psychopharmacology 33 (5), 675-681, 2013 | 113 | 2013 |
| A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning H Knegtering, M Boks, C Blijd, S Castelein, RJ Van den Bosch, ... Journal of sex & marital therapy 32 (4), 315-326, 2006 | 112 | 2006 |
André AlemanUniversity of Groningen, the Netherlands在 umcg.nl 的电子邮件经过验证
